Priority Date: 30.08.12 (US 201261695100P)

N-(3-FLUOROBENZYL)-2-(5-(4-MORPHOLINOPHENYL)PYRIDIN-2-YL) ACETAMIDE AS PROTEIN!TYROSINE KINASE MODULATORS

  • Application ID: EP13760222
  • Status: EXAMINATION IN PROGRESS

Attorneys

operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
no operation time available
2 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Grund Intellectual Property Group and Cooley (UK) LLP are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 30.08.2012 - Priority Date (US 201261695100P)
  • 06.03.2014 - Publication A1 (WO2014036426)
  • 08.07.2015 - Publication A1 (EP2890680)